Wednesday, July 8, 2026

biotech · Malignant Glioma · Prostate Cancer · CADL

Candel Therapeutics

NovaPharmaNews editorial coverage mentioning Candel Therapeutics — regulatory, clinical, and market analysis.

117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US HQ
1999 Founded
82 Employees
Public company Type
CADL · NYSE Ticker
Company details
Status
Public
HQ
117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US
Founded
1999
Employees
82
Programs
12
Drugs
4
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Candel Therapeutics — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Candel Therapeutics — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Candel Therapeutics yet.

Back to company overview →